Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations
Pharmaceuticals · 30.01.2026 · 19 (2) · 241
DOI: 10.3390/ph19020241 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.01.2026. Verfasst von Erkan Efe Okur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Silver nanoparticles (AgNPs) have been studied extensively in recent years due to their biological activities. In addition to their well-known antibacterial, antioxidant, and anti-inflammatory properties, AgNPs also exhibit anticancer properties. Increasing evidence from in vivo and in vitro studies demonstrates that AgNPs exert significant anticancer effects through multiple mechanisms, including oxidative stress, mitochondrial dysfunction, DNA damage, cell cycle arrest, and apoptosis. In addition to these mechanisms, inhibition of certain pathways is also an important mechanism that enables AgNPs to exhibit anticancer activity. Furthermore, green-synthesized AgNPs often exhibit enhanced biocompatibility and improved selective cytotoxicity against cancer cells. Despite these promising findings, concerns regarding AgNP-associated toxicity, non-specific cellular damage, and long-term safety remain major challenges limiting their clinical translation. Strategies such as size and shape optimization, surface functionalization, and combination therapies have been recommended to enhance anticancer efficacy while minimizing adverse effects on healthy cells. This review brings together recent studies, offers a broad perspective, and aims to present an objective viewpoint to fully explain the anticancer potential and current challenges of AgNPs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, Çanakkale 17100, Türkiye.
- European Institute for Membranes (IEM), UMR-5635, University of Montpellier, ENSCM, CNRS, Place Eugène Bataillon, CEDEX 5, F-34095 Montpellier, France.
ORCID-Profile: Erkan Efe Okur, Emir Akdaşçi, Furkan Eker, Mikhael Bechelany
Zitieren
APA
Okur, E. E., Akdaşçi, E., Eker, F., Bechelany, M., & Karav, S. (2026). Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations. Pharmaceuticals, 19(2), 241. https://doi.org/10.3390/ph19020241
Vancouver
Okur EE, Akdaşçi E, Eker F, Bechelany M, Karav S. Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations. Pharmaceuticals. 2026;19(2):241. doi:10.3390/ph19020241
BibTeX
@article{Okur2026,
author = {Okur, Erkan Efe and Akdaşçi, Emir and Eker, Furkan and Bechelany, Mikhael and Karav, Sercan},
title = {Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {2},
pages = {241},
doi = {10.3390/ph19020241}
}
EUVIMED